Roles for lipoprotein lipase in Alzheimer's disease: An association study

Microscopy Research and Technique

Volumn 50, Issue 4, 2000, Pages 291-296

  Baum, Larry ^a   Wiebusch, Heiko ^b   Pang, Chi Pui ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

AD; Alzheimer's disease; Dementia; Hippocampus; Lipoprotein lipase; LPL

Indexed keywords

GENES; LIPOPROTEINS; NEURODEGENERATIVE DISEASES;

ALZHEIMERS DISEASE; APOLIPOPROTEIN E; DEMENTIA; DISEASE RISKS; HIPPOCAMPUS; LIPOPROTEIN LIPASE; LIPOPROTEIN PARTICLES; LIPOPROTEIN RECEPTOR-RELATED PROTEINS;

BRAIN;

APOLIPOPROTEIN E; LIPID; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENOTYPE; HIPPOCAMPUS; HUMAN; LIPID TRANSPORT; MAJOR CLINICAL STUDY; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; PRIORITY JOURNAL; RISK FACTOR; SENILE DEMENTIA; SENILE PLAQUE;

EID: 0034663179     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0029(20000815)50:4<291::AID-JEMT8>3.0.CO;2-L     Document Type: Article

References (47)

1. Baum L, Baum E. 1999. Progressive diseases: Interpretation of genetic data. J Theoretical Med 2:1-7.
2. Baum L, Chen L, Ng HK, Chan YS, Mak YT, Woo J, Chiu HFK, Pang CP. 1998. Low density lipoprotein receptor related protein gene exon 3 polymorphism association with Alzheimer's disease in Chinese. Neurosci Lett 247:1-4.
3. Baum L, Chen L, Masliah E, Chan YS, Ng HK, Pang CP. 1999. Lipoprotein lipase mutations and Alzheimer's disease. Am J Med Genet 88:136-139.
4. Ben-Zeev O, Doolittle MH, Singh N, Chang CH, Schotz MC. 1990. Synthesis and regulation of lipoprotein lipase in the hippocampus. J Lipid Res 31:1307-1313.
5. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239-259.
6. Chait A, Robertson HT, Brunzell JD. 1981. Chylomicronemia syndrome in diabetes mellitus. Diabetes Care 4:343-348.
7. Chan L, Mak Y, Tomlinson B, Baum L, Wu X, Masarei J, Pang C. 2000. Compound heterozygosity of Leu252Val and Leu252Arg causing lipoprotein lipase deficiency in a Chinese patient with hypertriglyceridemia. Eur J Clin Invest 30:33-40.
8. Chen L, Baum L, Ng HK, Chan LY, Pang CP. 1999. Apolipoprotein E genotype and its pathological correlation in Chinese Alzheimer's disease with late onset. Human Pathol 30: 1172-1177.
9. Davies W. 1994. The molecular biology of lipoprotein lipase deficiency. Clin Biochem Revs 15:45-55.
10. De Bruin TWA, Mailly F, Van Barlingen HHJJ. 1996. Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia. Eur J Clin Invest 26:631-639.
11. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH. 1998. Neurogenesis in the adult human hippocampus. Nat Med 4:1313-1317.
12. Farooqui AA, Wallace LJ, Horrocks LA. 1991. Stimulation of mono- and diacylglycerol lipase activities in ibotenate-induced lesions of nucleus basalis magnocellularis. Neurosci Lett 131:97-99.
13. Fisher RM, Mailly F, Peacock RE. 1995. Interaction of the lipoprotein lipase asparagine 291 serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J Lipid Res 36:2104-2112.
14. Galton DJ, Mattu R, Needham EW, Cavanna J. 1996. Identification of putative beneficial mutations for lipid transport. Z Gastroenterol 34(Suppl)3:56-58.
15. Goldberg IJ. 1997. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 37:693-707.
16. Groenemeijer BE, Hallman MD, Reymer PW. 1997. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. Circulation 95:2628-2635.
17. Hegele RA, Gandhi S, Brunt JH, Connelly PW. 1996. Restriction isotyping of the premature termination variant of lipoprotein lipase in Alberta Hutterites. Clin Biochem 29:63-66.
18. Heilman KM, Fisher WR. 1974. Hyperlipidemic dementia. Arch Neurol 31:67-68.
19. Hoffer MJV, Bredie SJH, Boomsma D. 1996. The lipoprotein lipase (Asn291→Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia. Atherosclerosis 119:159-167.
20. Horsburgh K, Fitzpatrick M, Nilsen M, Nicoll JA. 1997. Marked alterations in the cellular localisation and levels of apolipoprotein E following acute subdural haematoma in rat. Brain Res 763:103-110.
21. Horsburgh K, Kelly S, McCulloch J, Higgins GA, Roses AD, Nicoll JA. 1999. Increased neuronal damage in apolipoprotein E-deficient mice following global ischaemia. Neuroreport 10:837-841.
22. Jemaa R, Fumeron F, Poirier O. 1995. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J Lipid Res 36:2141-2146.
23. Kamboh MI, Ferrell RE, DeKosky, ST. 1998. Genetic association studies between Alzheimer's disease and two polymorphisms in the low-density lipoprotein receptor-related protein gene. Neurosci Lett 244:65-68.
24. Kang DE, Saitoh T, Chen X, Xia Y, Masliah E, Hansen LA, Thomas RG, Thal LJ, Katzman R. 1997. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 49:56-61.
25. Kuusisto J, Koivisto K, Mykkänen L, Helkala EL, Vanhanen M, Hänninen T, Kervinen K, Kesäniemi YA, Riekkinen PJ, Laakso M. 1997. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein ∈4 phenotype: cross sectional population based study. Br Med J 315: 1045-1049.
26. Lambert JC, Wavrant-De Vrièze F, Amouyel P, Chartier-Harlin MC. 1998. Association at LRP gene locus with sporadic late-onset Alzheimer's disease. Lancet 351:1787.
27. Lorent K, Overbergh L, Moechars D, De Strooper B, Van Leuven F, Van Den Berghe H. 1995. Expression in mouse embryos and in adult mouse brain of three members of the amyloid precursor protein family, of the alpha-2-macroglobulin receptor/low density lipoprotein receptor-related protein and of its ligands apolipoprotein E, lipoprotein lipase, alpha-2-macroglobulin and the 40,000 molecular weight receptor-associated protein. Neurosci 65:1009-1025.
28. Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, Roses AD. 1995. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp Neurol 136:107-122.
29. Mathew NT, Meyer JS, Achari AN, Dodson RF. 1976. Hyperlipidemic neuropathy and dementia. Eur Neurol 14:370-382.
30. Nuñez M, Peinado-Onsurbe J, Vilaró S, Llobera M. 1995. Lipoprotein lipase activity in developing rat brain areas. Biol Neonate 68:119-127.
31. Peacock RE, Hamsten A, Nilsson-Ehle P, Humphries SE. 1992. Association between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 97:171-185.
32. Pimstone SN, Clee SM, Gagné SE. 1996. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers. J Lipid Res 37:1675-1684.
33. 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann Neurol 37:211-217.
34. Reymer PWA, Gagné E, Groenemeyer BE. 1995a. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. NatureGenetics 10:28-33.
35. Reymer PWA, Groenemeyer BE, Gagné E. 1995b. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum Mol Genet 4:1543-1549.
36. Roses AD, Saunders AM. 1994. APOE is a major susceptibility gene for Alzheimer's disease. Curr Opin Biotech 5:663-667.
37. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. 1997. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. New Engl J Med 336: 1216-1222.
38. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD. 1993. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:9649-9653.
39. Skoog I, Kalaria RN, Breteler MM. 1999. Vascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord 13 Suppl 3:S106-S114.
40. Snowdon D, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. 1997. Brain infarction and the clinical expression of Alzheimer disease: the nun study. JAMA 277:813-817.
41. Stocks J, Thorn JA, Galton DJ. 1992. Lipoprotein lipase genotypes for a common premature termination codon mutation detected by PCR-mediated site-directed mutagenesis and restriction digestion. J Lipid Res 33:853-857.
42. Strickland DK, Kounnas MZ, Argraves WS. 1995. LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J 9:890-898.
43. Wiebusch H, Funke H, Saku K, Arakawa K, Assmann G. 1997. Mutational analysis of two frequently observed lipoprotein lipase gene variants in the Japanese population. J Inher Metab Dis 20:108-109.
44. Wiebusch H, Poirier J, Sévigny P, Schappert K. 1999. Further evidence for a synergistic association between APOE ∈4 and BCHE-K in confirmed Alzheimer's disease. Hum Genet 104:158-163.
45. Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG. 1999. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation 99:2901-2907.
46. Zhang H, Reymer PWA, Liu M-S. 1995a. Patients with ApoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291 Ser mutation in the human LPL gene. Arterioscler Thromb Vasc Biol 15:1695-1703.
47. Zhang Q, Cavanna J, Winkelman BR, Shine B, Gross W, Marz W, Galton DJ. 1995b. Common genetic variants of lipoprotein lipase that relate to lipid transport in patients with premature coronary artery disease. Clin Genet 48:293-298.